Outlook Therapeutics Non-Current Deferred Revenue (Quarterly) Analysis

Outlook Therapeutics, Inc. (OTLK)

0.5742 -0.02 (-2.68%) USD | NASDAQ | Jan 12, 16:00

0.5676 -0.01 (-1.15%) Pre-Market: 09:23

View Non-Current Deferred Revenue (Quarterly) for OTLK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Ironwood Pharmaceuticals, Inc.	--
Amicus Therapeutics, Inc.	--
Neogen Corp.	--
CorMedix, Inc.	--
NovaBay Pharmaceuticals, Inc.	--